Baird Medical Investment Holdings Limited (BDMD) — Capital Reinvestment Ratio
Baird Medical Investment Holdings Limited (BDMD) has a Capital Reinvestment Ratio of 1.97x as of June 2023, meaning it reinvests 2% of its operating cash flow ($642.95K) in capital expenditures ($1.26 Million). Check Baird Medical Investment Holdings Limite tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Baird Medical Investment Holdings Limited Capital Reinvestment Ratio (2019–2022)
This chart tracks Baird Medical Investment Holdings Limited's Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see Baird Medical Investment Holdings Limite (BDMD) cash flow conversion.
Annual Capital Reinvestment Ratio for Baird Medical Investment Holdings Limited (2019–2022)
Year-by-year Capital Reinvestment Ratio for Baird Medical Investment Holdings Limited from 2019 to 2022. See BDMD free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 12.25x | $485.97K | $5.95 Million | ▲ +4539.9% |
| 2021 | 0.26x | $5.26 Million | $1.39 Million | ▲ +57.4% |
| 2020 | 0.17x | $3.91 Million | $655.35K | ▼ -24.8% |
| 2019 | 0.22x | $4.41 Million | $983.78K | — |